|
|
Post by parrerob on Jul 8, 2020 11:42:35 GMT -5
September
Receptor Life Sciences are presenting proof-of-concept clinical data addressing pressing cannabinoid delivery challenges
Interesting
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jul 8, 2020 16:45:31 GMT -5
September Receptor Life Sciences are presenting proof-of-concept clinical data addressing pressing cannabinoid delivery challenges Interesting COME BACK in 4 YEARS...... |
|
|
|
Post by sayhey24 on Jul 8, 2020 17:34:04 GMT -5
I wonder if they are giving out free samples. Maybe Mike can co-promote afrezza with RLS Technosphere - buy a box of afrezza and get a box of RLS. Maybe that would help with afrezza sales.
Its nice to see RLS is finally coming out of the shadows.
|
|
|
|
Post by peppy on Jul 8, 2020 19:22:38 GMT -5
September Receptor Life Sciences are presenting proof-of-concept clinical data addressing pressing cannabinoid delivery challengesInteresting I'm sorry, what the hell could the challenge be? |
|
|
|
Post by goyocafe on Jul 8, 2020 20:00:16 GMT -5
September Receptor Life Sciences are presenting proof-of-concept clinical data addressing pressing cannabinoid delivery challengesInteresting I'm sorry, what the hell could the challenge be? I think it's a timing issue. I like my cannabinoids to show up about 40 minutes before my pizza. |
|
|
|
Post by prcgorman2 on Jul 9, 2020 6:55:52 GMT -5
I will speculate a delivery challenge is a clinincally useful but very small dose administered as directly into the bloodstream as possible without IV. Oral and dermal pathways can be problematic right?
|
|
|
|
Post by markado on Jul 9, 2020 8:05:56 GMT -5
I will speculate a delivery challenge is a clinincally useful but very small dose administered as directly into the bloodstream as possible without IV. Oral and dermal pathways can be problematic right? I believe you are spot on prcg2. Clinically useful and appropriate/controlled dosing is a big challenge likely overcome by the use of technosphere tech. |
|
|
|
Post by mango on Jul 10, 2020 7:32:04 GMT -5
ALB is participating in 3 different presentations. One, is the clinical proof of concept Phase 0 data of their solid oral formulation(s) and Technosphere cannabinoid(s). Second, is a Q&A session, and lastly ALB is participating in a panel discussion concerning clinical trials.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jul 10, 2020 8:29:09 GMT -5
ALB is participating in 3 different presentations. One, is the clinical proof of concept Phase 0 data of their solid oral formulation(s) and Technosphere cannabinoid(s). Second, is a Q&A session, and lastly ALB is participating in a panel discussion concerning clinical trials. Nice to see progress but they are 4+ years away from any form of FDA approval. |
|
|
|
Post by mango on Jul 10, 2020 9:17:44 GMT -5
ALB is participating in 3 different presentations. One, is the clinical proof of concept Phase 0 data of their solid oral formulation(s) and Technosphere cannabinoid(s). Second, is a Q&A session, and lastly ALB is participating in a panel discussion concerning clinical trials. Nice to see progress but they are 4+ years away from any form of FDA approval. So what if they are? You cannot be so impatient when it comes to pharma. Nothing happens tomorrow in this industry, and you are naive and ignorant to believe otherwise. Clinical trials take time, that is just how it is. Fact remains, however, that with ALB having a significant involvement in this high profile International Cannabinoid Derived Pharmaceutical Summit, and presenting clinical data involving Technosphere inhaled cannabinoid(s), this is all VERY BULLISH. |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jul 10, 2020 9:27:30 GMT -5
Nice to see progress but they are 4+ years away from any form of FDA approval. So what if they are? You cannot be so impatient when it comes to pharma. Nothing happens tomorrow in this industry, and you are naive and ignorant to believe otherwise. Clinical trials take time, that is just how it is. Fact remains, however, that with ALB having a significant involvement in this high profile International Cannabinoid Derived Pharmaceutical Summit, and presenting clinical data involving Technosphere inhaled cannabinoid(s), this is all VERY BULLISH. No kidding. This is not my first rodeo. I am a long term investor hence my 6+ year journey with MNKD. |
|
